Invacare Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Invacare şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

29.4%

Geri Alım Getirisi

Toplam Hissedar Getirisi	29.4%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

May 14

Invacare EPS misses by $0.02, misses on revenue

May 05

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

May 03

Invacare Corporation's (NYSE:IVC) Path To Profitability

Mar 03

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Feb 05

What Can The Trends At Invacare (NYSE:IVC) Tell Us About Their Returns?

Jan 10

Invacare's(NYSE:IVC) Share Price Is Down 48% Over The Past Five Years.

Dec 14

Invacare Corporation's (NYSE:IVC) Shift From Loss To Profit

Nov 23

Invacare Corporation 2020 Q3 - Results - Earnings Call Presentation

Oct 30

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: IVCR.Q şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: IVCR.Q şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Invacare Piyasaya Karşı Temettü Getirisi

IVCR.Q temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (IVCR.Q)	0%
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Medical Equipment)	1.6%
Analist tahmini (IVCR.Q) (3 yıla kadar)	n/a

Önemli Temettü: IVCR.Q şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, IVCR.Q şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: IVCR.Q US piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: IVCR.Q herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Invacare Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

Invacare Corporation announced delayed 10-Q filing

Silverback Asset Management Engages with Invacare Corporation

Invacare Corporation announced delayed annual 10-K filing

Invacare Corporation announced delayed 10-Q filing

Invacare Corporation Enters Settlement Agreement with Sunrise Medical (Us) Llc and Sunrise Medical Gmbh

Invacare Holdings Corporation Announces Executive Changes

Invacare Corporation(OTCPK:IVCR.Q) dropped from S&P TMI Index

NYSE to Suspend Trading Immediately in Invacare Corporation and Commence Delisting Proceedings

Invacare Corporation Filed for Bankruptcy

Invacare falls on bankruptcy filing

Invacare Corporation Filed for Bankruptcy

Invacare announces additional draw of $5.5M term loans

Invacare Corporation Appoints Geoffrey P. Purtill as President

Price target decreased to US$1.65

Invacare Corporation (NYSE:IVC) Analysts Just Slashed Next Year's Estimates

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare GAAP EPS of -$0.92, revenue of $170.4M

Invacare Corporation to Report Q3, 2022 Results on Nov 07, 2022

Invacare Corporation Receives Notice of Noncompliance with NYSE Trading Share Price Listing Rule

Invacare receives non-compliance letter from NYSE

Invacare Corporation Announces Executive Changes

Invacare names Geoffrey Purtill as interim president and executive chief

Invacare Corporation Announces Board and Committee Appointments

Invacare adds two new directors after deal with largest investor Azurite

Consensus EPS estimates fall by 77%

Price target decreased to US$4.27

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q2, 2022 Results on Aug 08, 2022

Invacare Corporation(NYSE:IVC) dropped from Russell 2000 Value Index

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Invacare Corporation Introduces the Birdie Evo Xplus Patient Lift to the U.S. Market

Consensus EPS estimates fall by 43%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Invacare Corporation Reaffirms Revenue Guidance for the Full Year 2022

Returns Are Gaining Momentum At Invacare (NYSE:IVC)

Price target decreased to US$6.25

Invacare Corporation to Report Q1, 2022 Results on May 09, 2022

Invacare Corporation, Annual General Meeting, May 19, 2022

Consensus EPS estimates fall by 148%

Price target decreased to US$7.00

Full year 2021 earnings: EPS and revenues miss analyst expectations

Invacare Corporation to Report Q4, 2021 Results on Mar 08, 2022

Invacare Corporation Introduces Its Next Generation E-Fix Eco Power Assist Device to Transform the Manual Wheelchair

Invacare Corporation Introduces New, Narrow Version of Invacare® AVIVA® STORM RX™ Rear Wheel Drive Power Wheelchair

Invacare (NYSE:IVC) Use Of Debt Could Be Considered Risky

Invacare Announces New Features in LiNX® 3 Electronics

Senior VP & GM of EMEA Ralf Ledda has left the company

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

No longer forecast to breakeven

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.21 loss in 3Q 2020)

Here's Why Invacare (NYSE:IVC) Is Weighed Down By Its Debt Load

Price target decreased to US$11.33

Invacare Corporation Provides Sales Guidance for the Third Quarter and Full Year 2021

Independent Director Baiju Shah has left the company

Independent Director recently sold US$59k worth of stock

Consensus forecasts updated

When Should You Buy Invacare Corporation (NYSE:IVC)?

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.48 loss in 2Q 2020)

Invacare Corporation Introduces the Invacare® AVIVA STORM RX, a Next Generation Rear Wheel Drive Power Wheelchair

Increases to CEO Compensation Might Be Put On Hold For Now at Invacare Corporation (NYSE:IVC)

Consensus EPS estimates fall to -US$0.56

First quarter 2021 earnings released: US$0.41 loss per share (vs US$0.022 profit in 1Q 2020)

Invacare Corporation Reaffirms Earnings Guidance for the Full Year 2021

Invacare EPS misses by $0.02, misses on revenue

Returns On Capital Are Showing Encouraging Signs At Invacare (NYSE:IVC)

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations, earnings disappoint

Invacare Corporation's (NYSE:IVC) Path To Profitability

Invacare Corporation and Its Subsidiary, Alber Usa, LLC Introduces the Next Generation Alber E-Motion® Power Assist Device

Analysts update estimates

Full year 2020 earnings released: US$0.82 loss per share (vs US$1.59 loss in FY 2019)

Revenue beats expectations, earnings disappoint

New 90-day high: US$10.51

Invacare (NYSE:IVC) Has A Somewhat Strained Balance Sheet

Invacare Corporation to Report Q4, 2020 Results on Feb 10, 2021